543 related articles for article (PubMed ID: 31058922)
1. Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose.
Abouk R; Pacula RL; Powell D
JAMA Intern Med; 2019 Jun; 179(6):805-811. PubMed ID: 31058922
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States.
Smart R; Pardo B; Davis CS
Addiction; 2021 Jan; 116(1):6-17. PubMed ID: 32533570
[TBL] [Abstract][Full Text] [Related]
3. Legal changes to increase access to naloxone for opioid overdose reversal in the United States.
Davis CS; Carr D
Drug Alcohol Depend; 2015 Dec; 157():112-20. PubMed ID: 26507172
[TBL] [Abstract][Full Text] [Related]
4. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
[TBL] [Abstract][Full Text] [Related]
5. State laws that authorize pharmacists to prescribe naloxone are associated with increased naloxone dispensing in retail pharmacies.
Xu J; Mukherjee S
Drug Alcohol Depend; 2021 Oct; 227():109012. PubMed ID: 34482035
[TBL] [Abstract][Full Text] [Related]
6. Opioid-overdose laws association with opioid use and overdose mortality.
McClellan C; Lambdin BH; Ali MM; Mutter R; Davis CS; Wheeler E; Pemberton M; Kral AH
Addict Behav; 2018 Nov; 86():90-95. PubMed ID: 29610001
[TBL] [Abstract][Full Text] [Related]
7. State legal innovations to encourage naloxone dispensing.
Davis C; Carr D
J Am Pharm Assoc (2003); 2017; 57(2S):S180-S184. PubMed ID: 28073688
[TBL] [Abstract][Full Text] [Related]
8. Expert views on state-level naloxone access laws: a qualitative analysis of an online modified-Delphi process.
Grant S; Smart R
Harm Reduct J; 2022 Jun; 19(1):64. PubMed ID: 35676719
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Naloxone Access Laws on Fatal Synthetic Opioid Overdose Fatality Rates.
Tabatabai M; Cooper RL; Wilus DM; Edgerton RD; Ramesh A; MacMaster SA; Patel PN; Singh KP
J Prim Care Community Health; 2023; 14():21501319221147246. PubMed ID: 36625264
[TBL] [Abstract][Full Text] [Related]
10. Regional and temporal effects of naloxone access laws on opioid overdose mortality.
Cataife G; Dong J; Davis CS
Subst Abus; 2021; 42(3):329-338. PubMed ID: 31951788
[TBL] [Abstract][Full Text] [Related]
11. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
[TBL] [Abstract][Full Text] [Related]
12. Association Between a State Law Allowing Pharmacists to Dispense Naloxone Without a Prescription and Naloxone Dispensing Rates.
Gangal NS; Hincapie AL; Jandarov R; Frede SM; Boone JM; MacKinnon NJ; Koechlin K; DeFiore-Hyrmer J; Holthusen A; Heaton PC
JAMA Netw Open; 2020 Jan; 3(1):e1920310. PubMed ID: 32003819
[TBL] [Abstract][Full Text] [Related]
13. Reviewing state-mandated training requirements for naloxone-dispensing pharmacists.
Roberts AW; Carpenter DM; Smith A; Look KA
Res Social Adm Pharm; 2019 Feb; 15(2):222-225. PubMed ID: 29650444
[TBL] [Abstract][Full Text] [Related]
14. Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama.
Sisson ML; McMahan KB; Chichester KR; Galbraith JW; Cropsey KL
Int J Drug Policy; 2019 Dec; 74():229-235. PubMed ID: 31698165
[TBL] [Abstract][Full Text] [Related]
15. Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US.
Ballreich J; Mansour O; Hu E; Chingcuanco F; Pollack HA; Dowdy DW; Alexander GC
JAMA Netw Open; 2020 Nov; 3(11):e2023677. PubMed ID: 33146732
[TBL] [Abstract][Full Text] [Related]
16. Legal requirements and recommendations to prescribe naloxone.
Haffajee RL; Cherney S; Smart R
Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
[TBL] [Abstract][Full Text] [Related]
17. Predictors of US states' adoption of naloxone access laws, 2001-2017.
Bohler RM; Hodgkin D; Kreiner PW; Green TC
Drug Alcohol Depend; 2021 Aug; 225():108772. PubMed ID: 34052687
[TBL] [Abstract][Full Text] [Related]
18. Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States.
Sohn M; Talbert JC; Huang Z; Lofwall MR; Freeman PR
JAMA Netw Open; 2019 Jun; 2(6):e196215. PubMed ID: 31225895
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid Settlement.
Zang X; Skinner A; Krieger MS; Behrends CN; Park JN; Green TC; Walley AY; Morgan JR; Linas BP; Yedinak JL; Schackman BR; Marshall BDL
JAMA Netw Open; 2024 May; 7(5):e2413861. PubMed ID: 38814644
[TBL] [Abstract][Full Text] [Related]
20. Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from Medicaid.
Gertner AK; Domino ME; Davis CS
Drug Alcohol Depend; 2018 Sep; 190():37-41. PubMed ID: 29966851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
